Description

(4R)-4-[(5S,7S,8S,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is a high-purity steroidal intermediate of significant importance in advanced pharmaceutical synthesis. This compound serves as a critical building block for the development of novel therapeutic agents, particularly in the fields of endocrinology and metabolic disease research. It is essential for R&D laboratories and manufacturers engaged in the production of sophisticated steroid-based active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex steroid hormones and their analogs.
• Research & Development: Used in medicinal chemistry for the discovery and optimization of new drug candidates targeting nuclear receptors.
• Active Pharmaceutical Ingredient (API) Synthesis: Integral to the manufacturing process of high-value steroid-based APIs under controlled GMP environments.
• Biochemical Research: Employed as a standard or reference compound in studies of steroid metabolism and receptor-ligand interactions.
• Process Development: Utilized for scaling up and optimizing synthetic routes in pilot plants and commercial production facilities.

Basic Information

Product Name	(4R)-4-[(5S,7S,8S,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
CAS No.	84413-81-0
Molecular Formula	C24H38O4
Molecular Weight	390.56 g/mol
Synonyms	17β-Carboxyethyl-androstane-3β,7β-diol; 3β,7β-Dihydroxy-5β-androstane-17β-propanoic Acid; 5β-Androstane-3β,7β-diol-17β-propionic Acid; (3β,5β,7β,17β)-3,7-Dihydroxy-androstane-17-propanoic Acid; Steroid Dihydroxy Propanoic Acid Derivative; CAS 84413-81-0; A key steroidal diol carboxylic acid intermediate.
EINECS	Contact for details

Quality Control

Our (4R)-4-[(5S,7S,8S,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid is produced and controlled under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the exacting standards required for pharmaceutical R&D and synthesis. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a dry environment and opened under conditions of low humidity to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.